Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Leukemia 8Lymphoma 7Breast Neoplasms 6Lymphoma, Follicular 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Kidney Neoplasms 3Wilms Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Leukemia, Megakaryoblastic, Acute 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pleuropulmonary blastoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Etoposide 5Filgrastim 4Cisplatin 4Bleomycin 4Paclitaxel 3Ifosfamide 3Taxes 2Polymerase Chain Reaction 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Carboplatin 2sodium thiosulfate 1liposomal amphotericin B 1Thrombopoietin 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Immunohistochemistry 1Gemcitabine 1Electroacupuncture 1Docetaxel 1DNA Methylation 1Congresses as Topic 1Caspofungin 1Base Sequence 1Amplified Fragment Length Polymorphism Analysis 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Testicular Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01433224 2016-05-18

Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression

Children's Oncology Group

Completed
90 enrolled
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡